Individualized trajectories in postradiotherapy neurocognitive functioning of patients with brain metastases
Open Access
- 29 March 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 11 (4) , 441-451
Abstract
The increasing incidence of brain metastases (BMs) and improved survival rates underscore the necessity to investigate the effects of treatments on individuals. The aim of this study was to evaluate the individual trajectories of subjective and objective cognitive performance after radiotherapy in patients with BMs. The study population consisted of adult patients with BMs referred for radiotherapy. A semi-structured interview and comprehensive neurocognitive assessment (NCA) were used to assess both subjective and objective cognitive performance before, 3 months and ≥ 11 months after radiotherapy. Reliable change indices were used to identify individual, clinically meaningful changes. Thirty-six patients completed the 3-month follow-up, and 14 patients completed the ≥ 11-months follow-up. Depending on the domain, subjective cognitive decline was reported by 11–22% of patients. In total, 50% of patients reported subjective decline in at least one cognitive domain. Intracranial progression 3 months postradiotherapy was a risk-factor for self-reported deterioration (P = .031). Objective changes were observed across all domains, with a particular vulnerability for decline in memory at 3 months postradiotherapy. The majority of patients (81%) experienced both a deterioration as well as improvement (eg, mixed response) in objective cognitive functioning. Results were similar for the long-term follow-up (3 to ≥11 months). No risk factors for objective cognitive change 3 months postradiotherapy were identified. Our study revealed that the majority of patients with BMs will show a mixed cognitive response following radiotherapy, reflecting the complex impact. This underscores the importance of patient-tailored NCAs 3 months postradiotherapy to guide optimal rehabilitation strategies.Keywords
Funding Information
- Dutch Cancer Society (#11110)
This publication has 50 references indexed in Scilit:
- Different profiles of neurocognitive functioning in patients with brain metastases prior to brain radiotherapyPsycho-Oncology, 2023
- Neurological outcome and memory performance in patients with 10 or more brain metastases treated with frameless linear accelerator (LINAC)-based stereotactic radiosurgeryJournal of Neuro-Oncology, 2020
- Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapyJournal of Neuro-Oncology, 2018
- Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain MetastasesJAMA, 2016
- Cognition in patients with newly diagnosed brain metastasis: profiles and implicationsJournal of Neuro-Oncology, 2014
- A prospective study of cognitive function in men with non‐seminomatous germ cell tumorsPsycho-Oncology, 2013
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Chemotherapy-Related Cognitive DysfunctionCurrent Neurology and Neuroscience Reports, 2012
- Epidemiology of Brain MetastasesCurrent Oncology Reports, 2011
- Presentation, patterns of care, and survival in patients with brain metastasesCancer, 2010